This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Smithkline Beecham Biologicals S.a.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Brigitte Desiree Colau: Innovator in Vaccine Development
Introduction
Brigitte Desiree Colau is a notable inventor based in Genval, Belgium. She has made significant contributions to the field of vaccine development, particularly in the fight against mumps. Her work has been instrumental in advancing public health through innovative solutions.
Latest Patents
Colau holds a patent for a vaccine against mumps that utilizes the Jeryl-Lynn virus strain. This patent represents a crucial step in enhancing the effectiveness of mumps vaccinations and showcases her commitment to improving health outcomes.
Career Highlights
Brigitte Desiree Colau is associated with SmithKline Beecham Biologicals S.A., where she has played a vital role in research and development. Her expertise in vaccine technology has positioned her as a key figure in the industry.
Collaborations
Throughout her career, Colau has collaborated with esteemed colleagues, including Nigel Maurice Harford and Jean Didelez. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Brigitte Desiree Colau's contributions to vaccine development, particularly her patent for a mumps vaccine, highlight her dedication to advancing medical science. Her work continues to impact public health positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile